Article preview reprinted Medtech Insight - January 2009
Find out how over the last 15 years, a trend toward evidence-based medicine has led to a greater understanding of the science behind wound healing.
Wound Care Devices: Growth Amid Uncertainty
Article preview reprinted Medtech Insight - January 2009
The market for wound care products has come a long way since the days when wet-to-dry dressing changes were one of the only options for treating chronic wounds. In the last 15 years, a trend toward evidence-based medicine has led to a greater understanding of the science behind wound healing and the mechanisms involved in nonhealing wounds. This knowledge has helped fuel an explosion of innovation in wound care technology and the commercialization of a wide range of exciting new therapeutic products designed to accelerate the wound healing process, minimize infection, and convert a chronic, stagnant wound into one that is actively healing.
Purchase this article online as a PDF and receive it immediately via email. Questions? Call (800) 332-2181. 100% Satisfaction Guaranteed.
Companies mentioned in this article:
Boehringer Ingelheim GMBH
Boehringer Ingelheim Corp.
Celleration Inc.
ConvaTec
Kinetic Concepts Inc.
LifeCell Corp.
Misonix Inc.
PolyRemedy Inc.
Smith & Nephew PLC
BlueSky Medical Group Inc.
Smith & Nephew Inc.
University of Alabama
University of Alabama at Birmingham
Wake Forest University
START-UP: No publication reviews leading edge companies and technology better than START-UP. Each issue of START-UP profiles the most important new product companies, identifies the hottest technology areas, reviews funds flowing into private companies and investment trends, and reports on university tech transfer licensing. Industries covered: pharmaceuticals, biotechnology, medical equipment & devices, and in vitro diagnostics. Subscribe to START-UP.
